Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 16 | 2025 | 1896 | 2.750 |
Why?
|
| Patient Satisfaction | 7 | 2021 | 472 | 1.800 |
Why?
|
| Ambulatory Care Facilities | 5 | 2022 | 225 | 1.010 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2024 | 424 | 0.830 |
Why?
|
| Lost to Follow-Up | 1 | 2022 | 33 | 0.750 |
Why?
|
| Mentoring | 1 | 2022 | 76 | 0.690 |
Why?
|
| Patient Outcome Assessment | 2 | 2022 | 92 | 0.680 |
Why?
|
| Helicobacter pylori | 3 | 2019 | 1324 | 0.640 |
Why?
|
| Helicobacter Infections | 3 | 2019 | 1267 | 0.640 |
Why?
|
| Medication Adherence | 2 | 2020 | 397 | 0.640 |
Why?
|
| Trust | 2 | 2017 | 76 | 0.640 |
Why?
|
| Patients | 1 | 2019 | 119 | 0.590 |
Why?
|
| Waiting Lists | 1 | 2019 | 227 | 0.560 |
Why?
|
| Texas | 11 | 2025 | 3572 | 0.550 |
Why?
|
| Influenza Vaccines | 1 | 2022 | 480 | 0.550 |
Why?
|
| Patient Participation | 1 | 2019 | 218 | 0.520 |
Why?
|
| Occupational Diseases | 2 | 2014 | 74 | 0.500 |
Why?
|
| Influenza, Human | 1 | 2022 | 662 | 0.500 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 2014 | 18 | 0.470 |
Why?
|
| Carrier State | 1 | 2014 | 76 | 0.450 |
Why?
|
| Nasal Cavity | 1 | 2014 | 50 | 0.450 |
Why?
|
| Metallurgy | 1 | 2014 | 6 | 0.450 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2023 | 933 | 0.450 |
Why?
|
| Patient-Centered Care | 1 | 2017 | 220 | 0.450 |
Why?
|
| Heat Stress Disorders | 1 | 2014 | 10 | 0.450 |
Why?
|
| Hot Temperature | 1 | 2014 | 136 | 0.430 |
Why?
|
| Veterans | 2 | 2023 | 1715 | 0.430 |
Why?
|
| Heart-Assist Devices | 1 | 2022 | 1026 | 0.420 |
Why?
|
| Physician-Patient Relations | 1 | 2017 | 427 | 0.410 |
Why?
|
| Occupational Exposure | 2 | 2014 | 129 | 0.400 |
Why?
|
| Liver Neoplasms | 1 | 2023 | 1316 | 0.400 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2014 | 220 | 0.390 |
Why?
|
| Qualitative Research | 4 | 2019 | 535 | 0.380 |
Why?
|
| Interviews as Topic | 4 | 2019 | 372 | 0.380 |
Why?
|
| Culture | 1 | 2012 | 68 | 0.370 |
Why?
|
| Anti-Bacterial Agents | 3 | 2017 | 2371 | 0.360 |
Why?
|
| Polymerase Chain Reaction | 1 | 2014 | 1592 | 0.360 |
Why?
|
| Emigrants and Immigrants | 2 | 2013 | 142 | 0.350 |
Why?
|
| Longitudinal Studies | 3 | 2019 | 1319 | 0.340 |
Why?
|
| Anxiety | 1 | 2017 | 943 | 0.340 |
Why?
|
| Health Resorts | 1 | 2010 | 1 | 0.340 |
Why?
|
| Swimming Pools | 1 | 2010 | 7 | 0.340 |
Why?
|
| Middle Aged | 15 | 2025 | 26688 | 0.340 |
Why?
|
| Humans | 30 | 2025 | 125138 | 0.320 |
Why?
|
| Respiratory Tract Diseases | 1 | 2010 | 75 | 0.320 |
Why?
|
| Patient Compliance | 1 | 2013 | 470 | 0.320 |
Why?
|
| Adult | 16 | 2025 | 29470 | 0.310 |
Why?
|
| Eye Diseases | 1 | 2010 | 117 | 0.300 |
Why?
|
| Surveys and Questionnaires | 7 | 2025 | 3675 | 0.290 |
Why?
|
| Anti-Retroviral Agents | 2 | 2025 | 141 | 0.250 |
Why?
|
| Attitude of Health Personnel | 2 | 2025 | 668 | 0.250 |
Why?
|
| Cross-Sectional Studies | 6 | 2021 | 3403 | 0.250 |
Why?
|
| Internship and Residency | 3 | 2023 | 1179 | 0.240 |
Why?
|
| Communication | 2 | 2022 | 507 | 0.240 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2024 | 847 | 0.240 |
Why?
|
| AIDS Vaccines | 1 | 2024 | 30 | 0.220 |
Why?
|
| Male | 18 | 2025 | 61465 | 0.220 |
Why?
|
| Patient Care | 2 | 2016 | 100 | 0.220 |
Why?
|
| Drug Monitoring | 1 | 2025 | 172 | 0.210 |
Why?
|
| Drug Therapy, Combination | 2 | 2017 | 1158 | 0.210 |
Why?
|
| Internal Medicine | 3 | 2023 | 147 | 0.210 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2021 | 729 | 0.210 |
Why?
|
| Teaching Rounds | 1 | 2023 | 28 | 0.210 |
Why?
|
| Prospective Studies | 3 | 2022 | 6124 | 0.210 |
Why?
|
| Female | 16 | 2025 | 66719 | 0.200 |
Why?
|
| Humidity | 2 | 2014 | 25 | 0.190 |
Why?
|
| Nephrologists | 1 | 2021 | 13 | 0.180 |
Why?
|
| Feedback | 1 | 2022 | 162 | 0.180 |
Why?
|
| Delivery of Health Care | 2 | 2016 | 615 | 0.170 |
Why?
|
| Health Personnel | 1 | 2025 | 506 | 0.170 |
Why?
|
| Pharmacists | 1 | 2020 | 85 | 0.170 |
Why?
|
| Feasibility Studies | 1 | 2022 | 760 | 0.160 |
Why?
|
| Sexual and Gender Minorities | 1 | 2020 | 64 | 0.160 |
Why?
|
| Aged | 6 | 2021 | 19666 | 0.150 |
Why?
|
| Social Support | 1 | 2020 | 340 | 0.150 |
Why?
|
| Ambulatory Care | 1 | 2021 | 390 | 0.150 |
Why?
|
| Pandemics | 2 | 2023 | 1112 | 0.140 |
Why?
|
| Health Services Research | 1 | 2019 | 184 | 0.140 |
Why?
|
| AIDS Serodiagnosis | 1 | 2018 | 56 | 0.140 |
Why?
|
| United States | 5 | 2022 | 10884 | 0.140 |
Why?
|
| Vaccination | 1 | 2022 | 961 | 0.130 |
Why?
|
| Amoxicillin | 1 | 2017 | 121 | 0.130 |
Why?
|
| Formative Feedback | 1 | 2016 | 30 | 0.130 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2016 | 231 | 0.130 |
Why?
|
| Preceptorship | 1 | 2016 | 33 | 0.130 |
Why?
|
| Medical Staff, Hospital | 1 | 2016 | 93 | 0.120 |
Why?
|
| Health Care Surveys | 2 | 2016 | 283 | 0.120 |
Why?
|
| Prevalence | 2 | 2014 | 2458 | 0.120 |
Why?
|
| Hospitals, Veterans | 1 | 2017 | 350 | 0.120 |
Why?
|
| Renal Dialysis | 1 | 2021 | 861 | 0.110 |
Why?
|
| Hospitals, Urban | 1 | 2014 | 97 | 0.110 |
Why?
|
| Specific Gravity | 1 | 2014 | 4 | 0.110 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2017 | 358 | 0.110 |
Why?
|
| Aluminum | 1 | 2014 | 12 | 0.110 |
Why?
|
| Veterans Health | 1 | 2016 | 175 | 0.110 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2017 | 791 | 0.110 |
Why?
|
| Telemedicine | 1 | 2020 | 436 | 0.110 |
Why?
|
| Proton Pump Inhibitors | 1 | 2017 | 278 | 0.110 |
Why?
|
| Electrolytes | 1 | 2014 | 53 | 0.110 |
Why?
|
| Decision Making | 1 | 2019 | 656 | 0.110 |
Why?
|
| Body Temperature | 1 | 2014 | 117 | 0.110 |
Why?
|
| Retrospective Studies | 3 | 2023 | 16350 | 0.100 |
Why?
|
| Social Stigma | 2 | 2024 | 72 | 0.090 |
Why?
|
| Herpes Zoster | 1 | 2011 | 23 | 0.090 |
Why?
|
| Physicians | 1 | 2018 | 581 | 0.090 |
Why?
|
| Monitoring, Physiologic | 1 | 2014 | 377 | 0.090 |
Why?
|
| Spinal Cord Diseases | 1 | 2011 | 37 | 0.090 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2013 | 260 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 1265 | 0.090 |
Why?
|
| Heart Rate | 1 | 2014 | 582 | 0.090 |
Why?
|
| Young Adult | 3 | 2020 | 9060 | 0.090 |
Why?
|
| Regression Analysis | 1 | 2012 | 777 | 0.090 |
Why?
|
| Chloramines | 1 | 2010 | 5 | 0.080 |
Why?
|
| Models, Statistical | 1 | 2013 | 470 | 0.080 |
Why?
|
| Air Pollutants, Occupational | 1 | 2010 | 18 | 0.080 |
Why?
|
| Environmental Microbiology | 1 | 2010 | 16 | 0.080 |
Why?
|
| Endotoxins | 1 | 2010 | 48 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 2056 | 0.080 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 859 | 0.080 |
Why?
|
| Temperature | 1 | 2010 | 307 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 2182 | 0.080 |
Why?
|
| Health Services Accessibility | 1 | 2012 | 605 | 0.070 |
Why?
|
| Anti-HIV Agents | 1 | 2025 | 321 | 0.050 |
Why?
|
| Reimbursement Mechanisms | 1 | 2021 | 36 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2013 | 12276 | 0.040 |
Why?
|
| Homosexuality, Male | 1 | 2020 | 63 | 0.040 |
Why?
|
| Risk Factors | 1 | 2014 | 10284 | 0.040 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2021 | 164 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2011 | 3050 | 0.040 |
Why?
|
| Inpatients | 1 | 2023 | 497 | 0.040 |
Why?
|
| Chicago | 1 | 2018 | 20 | 0.040 |
Why?
|
| Medicare | 1 | 2021 | 427 | 0.040 |
Why?
|
| Perception | 1 | 2018 | 220 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 308 | 0.030 |
Why?
|
| Focus Groups | 1 | 2016 | 190 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2018 | 370 | 0.030 |
Why?
|
| Kidney Failure, Chronic | 1 | 2021 | 887 | 0.030 |
Why?
|
| Mass Screening | 1 | 2018 | 783 | 0.020 |
Why?
|
| Adolescent | 1 | 2010 | 19424 | 0.020 |
Why?
|
| Methylprednisolone | 1 | 2011 | 93 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2011 | 173 | 0.020 |
Why?
|
| Carcinoma, Papillary | 1 | 2011 | 71 | 0.020 |
Why?
|
| Exanthema | 1 | 2011 | 71 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2016 | 766 | 0.020 |
Why?
|
| Thyroid Neoplasms | 1 | 2011 | 189 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2011 | 292 | 0.020 |
Why?
|
| Carcinoma | 1 | 2011 | 289 | 0.020 |
Why?
|
| Pediatrics | 1 | 2017 | 1158 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 2011 | 426 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 3606 | 0.010 |
Why?
|